Literature DB >> 27020052

Hashimoto's thyroiditis could be secondary to vitiligo: the possibility of antigen crossover and oxidative stress between the two diseases.

Qingli Gong1, Xue Li1, Qixing Gong2, Wenyuan Zhu1, Guoxin Song2, Yan Lu3.   

Abstract

Autoimmune thyroid diseases (AITDs) are often accompanied by vitiligo, and the sera of patients with vitiligo often demonstrate increased frequencies of thyroid autoantibodies. In this study, we investigated the expression of melanocyte-associated antigens in tissues from patients with Hashimoto's thyroiditis (HT) without vitiligo using immunohistochemistry. Tissues of HT without vitiligo, as well as normal thyroid tissues, were both negative for the expression of NKI/beteb, gp100, tyrosinase-related protein 1 (TRP1), HMB-45 and S100, whereas they were positive for the expression of tyrosinase-related protein 2 (TRP2), lysosome-associated membrane protein 1 (LAMP1) and CD69. Tyrosinase (TYR) was only detected in tissues of HT, and levels of LAMP1 and CD69 were higher in tissues of HT than in normal thyroid tissues (p < 0.005). These results suggest the possibility of antigen crossover and oxidative stress between vitiligo and HT that might represent an immunological basis for secondary HT associated with vitiligo.

Entities:  

Keywords:  Hashimoto’s thyroiditis; Immunohistochemistry; Melanocytes; Oxidative stress; Vitiligo

Mesh:

Substances:

Year:  2016        PMID: 27020052     DOI: 10.1007/s00403-016-1641-z

Source DB:  PubMed          Journal:  Arch Dermatol Res        ISSN: 0340-3696            Impact factor:   3.017


  5 in total

Review 1.  Thyroid diseases and skin autoimmunity.

Authors:  Enke Baldini; Teresa Odorisio; Chiara Tuccilli; Severino Persechino; Salvatore Sorrenti; Antonio Catania; Daniele Pironi; Giovanni Carbotta; Laura Giacomelli; Stefano Arcieri; Massimo Vergine; Massimo Monti; Salvatore Ulisse
Journal:  Rev Endocr Metab Disord       Date:  2018-12       Impact factor: 6.514

2.  Prevalence of Thyroid Abnormalities in Thai Patients with Vitiligo.

Authors:  Vasanop Vachiramon; Sarawin Harnchoowong; Woranit Onprasert; Kumutnart Chanprapaph
Journal:  Biomed Res Int       Date:  2017-12-07       Impact factor: 3.411

3.  Factors Associated with Development of Vitiligo in Patients with Halo Nevus.

Authors:  Hui Zhou; Liang-Cai Wu; Mu-Kai Chen; Qi-Man Liao; Ren-Xiang Mao; Jian-De Han
Journal:  Chin Med J (Engl)       Date:  2017-11-20       Impact factor: 2.628

Review 4.  Vitiligo and Autoimmune Thyroid Disorders.

Authors:  Enke Baldini; Teresa Odorisio; Salvatore Sorrenti; Antonio Catania; Francesco Tartaglia; Giovanni Carbotta; Daniele Pironi; Roberta Rendina; Eleonora D'Armiento; Severino Persechino; Salvatore Ulisse
Journal:  Front Endocrinol (Lausanne)       Date:  2017-10-27       Impact factor: 5.555

5.  A Case of Oculocutaneous Albinism in a Patient with Hashimoto's Thyroiditis.

Authors:  Giovanni de Gennaro; Paolo Vitti; Michele Marinò
Journal:  Eur Thyroid J       Date:  2018-10-16
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.